Back
Alnylam Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
ALNY
Alnylam Pharmaceuticals
Last Price:
$256.54
Seasonality Move:
20.34%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.
Alnylam Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 244.03 | Buy |
| 20-day SMA: | 241.94 | Buy |
| 50-day SMA: | 249.33 | Buy |
| 200-day SMA: | 258.64 | Sell |
| 8-day EMA: | 247.15 | Buy |
| 20-day EMA: | 245.59 | Buy |
| 50-day EMA: | 249.39 | Buy |
| 200-day EMA: | 244.3 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.99 | Sell |
| Relative Strength Index (14 RSI): | 56.56 | Buy |
| Chaikin Money Flow: | 2387 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (231.78 - 264.1) | Buy |
| Bollinger Bands (100): | (237.06 - 266.98) | Buy |
Alnylam Pharmaceuticals Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 257.19 while ALNY 8-day simple moving average is 244.03, which is a Buy signal.
-
The stock price of ALNY is 257.19 while Alnylam Pharmaceuticals 20-day SMA is 241.94, which makes it a Buy.
-
Alnylam Pharmaceuticals 50-day simple moving average is 249.33 while ALNY share price is 257.19, making it a Buy technically.
-
ALNY stock price is 257.19 and Alnylam Pharmaceuticals 200-day simple moving average is 258.64, creating a Sell signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
48
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a SellThe current Alnylam Pharmaceuticals [ALNY] share price is $257.19. The Score for ALNY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
33.3B
Price in USD:
257.19
Share Volume:
941.6K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
304.39
52-Week Low:
143.81
Sell
48
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?The Alnylam Pharmaceuticals stock price is 257.19 USD today.
-
Will ALNY stock go up or go down?Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Alnylam Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 257.19 while ALNY 8-day exponential moving average is 247.15, which is a Buy signal.
-
The stock price of ALNY is 257.19 while Alnylam Pharmaceuticals 20-day EMA is 245.59, which makes it a Buy.
-
Alnylam Pharmaceuticals 50-day exponential moving average is 249.39 while ALNY share price is 257.19, making it a Buy technically.
-
ALNY stock price is 257.19 and Alnylam Pharmaceuticals 200-day simple moving average is 244.30, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $1.38 per share, an increase this year of $0.96 per share, and an increase next year of $2.88 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
-
ALNY Moving Average Covergence Divergence (MACD) indicator is -0.99, suggesting Alnylam Pharmaceuticals is a Sell
-
Alnylam Pharmaceuticals Relative Strength Index (RSI) is 56.56, which suggest Alnylam Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Alnylam Pharmaceuticals is (231.78 - 264.1), which suggest Alnylam Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Alnylam Pharmaceuticals is (237.06 - 266.98), which suggest Alnylam Pharmaceuticals is a Buy
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.